Mills Roger sold (to issuer) 392,837 shares of ADXN
Mills Roger (CHIEF MEDICAL OFFICER) sold (to issuer) 392,837 shares of Addex Therapeutics Ltd. (ADXN) on 2026-09-02.
How this was made
The 30-second read
Why it matters
The sale represents a modest reduction in insider holdings without price details, suggesting low immediate market impact.
Market read
Minor insider sale with limited trading relevance.
What to watch
No price disclosed; market may not react until price is known.
Background
Form 4 filings disclose insider transactions; investors monitor for signals.
Ticker impact
Chief Medical Officer sold 392,837 shares to the issuer on 2026-09-02 via a Form 4 filing.
Minor downward pressure, likely within normal volatility range.
Sale size is modest relative to typical float; no disclosed price or market reaction.
Market effects
Limited impact on biotech sector; insider transactions are routine.
None
None
Counterpoint
Sale could be a red flag if insider confidence wanes, but could also be unrelated liquidity need.
Key entities
- OfficerMills Roger
Chief Medical Officer of Addex Therapeutics Ltd.